DK3418275T3 - Hidtil ukendt 2,3,5-substitueret thiophenforbindelse som proteinkinasehæmmer - Google Patents
Hidtil ukendt 2,3,5-substitueret thiophenforbindelse som proteinkinasehæmmer Download PDFInfo
- Publication number
- DK3418275T3 DK3418275T3 DK17753486.4T DK17753486T DK3418275T3 DK 3418275 T3 DK3418275 T3 DK 3418275T3 DK 17753486 T DK17753486 T DK 17753486T DK 3418275 T3 DK3418275 T3 DK 3418275T3
- Authority
- DK
- Denmark
- Prior art keywords
- substituted thiophene
- thiophene compound
- hitherto unknown
- proteinkinase inhibitors
- proteinkinase
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/08—Hydrogen atoms or radicals containing only hydrogen and carbon atoms
- C07D333/10—Thiophene
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160017991 | 2016-02-16 | ||
| PCT/KR2017/001715 WO2017142325A1 (ko) | 2016-02-16 | 2017-02-16 | 단백질 키나아제 저해제인 신규 2,3,5-치환된 싸이오펜 화합물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3418275T3 true DK3418275T3 (da) | 2021-05-10 |
Family
ID=59626142
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17753486.4T DK3418275T3 (da) | 2016-02-16 | 2017-02-16 | Hidtil ukendt 2,3,5-substitueret thiophenforbindelse som proteinkinasehæmmer |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10442796B2 (da) |
| EP (1) | EP3418275B1 (da) |
| JP (2) | JP6749422B2 (da) |
| KR (3) | KR20170096599A (da) |
| CN (1) | CN108884066B (da) |
| AU (1) | AU2017221707B2 (da) |
| BR (1) | BR112018016729B1 (da) |
| CA (1) | CA3014740C (da) |
| DK (1) | DK3418275T3 (da) |
| ES (1) | ES2866890T3 (da) |
| HK (1) | HK1258053A1 (da) |
| MX (1) | MX2018009861A (da) |
| NZ (1) | NZ745210A (da) |
| PT (1) | PT3418275T (da) |
| RU (1) | RU2724957C2 (da) |
| WO (1) | WO2017142325A1 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2724957C2 (ru) * | 2016-02-16 | 2020-06-29 | Корея Инститьют Оф Сайенс Энд Текнолоджи | Новое соединение 2,3,5-замещенного тиофена в качестве ингибитора протеинкиназы |
| KR102227117B1 (ko) | 2018-05-30 | 2021-03-15 | (주)파로스아이바이오 | 2,3,5-치환된 싸이오펜 화합물의 유방암 예방, 개선 또는 치료 용도 |
| WO2019231221A1 (ko) * | 2018-05-30 | 2019-12-05 | (주)파로스아이비티 | 2,3,5-치환된 싸이오펜 화합물의 방사선 치료 증진 용도 |
| TWI727392B (zh) * | 2018-08-13 | 2021-05-11 | 美商基利科學股份有限公司 | 噻二唑irak4抑制劑 |
| CN110643672A (zh) * | 2019-10-15 | 2020-01-03 | 西安交通大学 | 高表达TrkB作为新型靶点在抑制胰腺癌转移方面的医药用途 |
| EP4115883A4 (en) * | 2020-03-04 | 2024-04-10 | Pharos Ibio Co Ltd | USE OF A 2,3,5-SUBSTITUTED THIOPHENE COMPOUND TO PREVENT, MITIGATE OR TREAT OVARIAN CANCER |
| KR102578970B1 (ko) * | 2020-03-04 | 2023-09-15 | (주)파로스아이바이오 | 2,3,5-치환된 싸이오펜 화합물의 난소암 예방, 개선 또는 치료 용도 |
| KR102535842B1 (ko) * | 2020-07-31 | 2023-05-23 | (주)파로스아이바이오 | 2,3,5-치환된 싸이오펜 화합물의 비만세포증 예방, 개선 또는 치료 용도 |
| KR102535840B1 (ko) * | 2020-07-31 | 2023-05-23 | (주)파로스아이바이오 | 2,3,5-치환된 싸이오펜 화합물의 위장관기질종양 예방, 개선 또는 치료 용도 |
| WO2023063784A1 (ko) * | 2021-10-14 | 2023-04-20 | (주)파로스아이바이오 | 2,3,5-치환된 싸이오펜 화합물을 포함하는 병용 투여용 조성물 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5728868A (en) * | 1993-07-15 | 1998-03-17 | Cancer Research Campaign Technology Limited | Prodrugs of protein tyrosine kinase inhibitors |
| US6414013B1 (en) * | 2000-06-19 | 2002-07-02 | Pharmacia & Upjohn S.P.A. | Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention |
| NZ540161A (en) * | 2002-10-30 | 2008-03-28 | Vertex Pharma | Compositions useful as inhibitors of rock and other protein kinases |
| JP2005064770A (ja) * | 2003-08-11 | 2005-03-10 | Ricoh Co Ltd | 情報処理装置、認証装置、外部装置、証明情報取得方法、認証方法、機能提供方法、証明情報取得プログラム、認証プログラム、機能提供プログラム及び記録媒体 |
| US20050085531A1 (en) * | 2003-10-03 | 2005-04-21 | Hodge Carl N. | Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| CA2552050C (en) * | 2004-01-05 | 2011-08-09 | Astrazeneca Ab | Substituted heterocycles and the uses thereof |
| JP2007531757A (ja) * | 2004-03-30 | 2007-11-08 | カイロン コーポレイション | 抗癌剤としての置換チオフェン誘導体 |
| JP2008534565A (ja) * | 2005-03-31 | 2008-08-28 | アストラゼネカ アクチボラグ | Ｔｉｅ２阻害活性のあるアミノピリミジン誘導体 |
| KR100703622B1 (ko) * | 2005-10-26 | 2007-04-06 | 삼성전기주식회사 | 캡 방식의 카메라 모듈 |
| JP5581219B2 (ja) * | 2008-01-25 | 2014-08-27 | ミレニアム ファーマシューティカルズ， インコーポレイテッド | チオフェンおよびホスファチジルイノシトール３−キナーゼ（ｐｉ３ｋ）阻害薬としてのその使用 |
| MX336051B (es) * | 2011-01-21 | 2016-01-07 | Sun Pharma Advanced Res Co Ltd | Diarilacetileno hidracido que contiene inhibidores de tirosina quinasa. |
| RU2724957C2 (ru) * | 2016-02-16 | 2020-06-29 | Корея Инститьют Оф Сайенс Энд Текнолоджи | Новое соединение 2,3,5-замещенного тиофена в качестве ингибитора протеинкиназы |
-
2017
- 2017-02-16 RU RU2018130703A patent/RU2724957C2/ru active
- 2017-02-16 AU AU2017221707A patent/AU2017221707B2/en active Active
- 2017-02-16 PT PT177534864T patent/PT3418275T/pt unknown
- 2017-02-16 ES ES17753486T patent/ES2866890T3/es active Active
- 2017-02-16 EP EP17753486.4A patent/EP3418275B1/en active Active
- 2017-02-16 CN CN201780021441.1A patent/CN108884066B/zh active Active
- 2017-02-16 CA CA3014740A patent/CA3014740C/en active Active
- 2017-02-16 KR KR1020170020896A patent/KR20170096599A/ko active Application Filing
- 2017-02-16 WO PCT/KR2017/001715 patent/WO2017142325A1/ko active Application Filing
- 2017-02-16 DK DK17753486.4T patent/DK3418275T3/da active
- 2017-02-16 BR BR112018016729-0A patent/BR112018016729B1/pt active IP Right Grant
- 2017-02-16 MX MX2018009861A patent/MX2018009861A/es unknown
- 2017-02-16 JP JP2018561463A patent/JP6749422B2/ja active Active
- 2017-02-16 NZ NZ745210A patent/NZ745210A/en unknown
-
2018
- 2018-08-16 US US15/998,791 patent/US10442796B2/en active Active
- 2018-12-17 KR KR1020180163545A patent/KR101965326B1/ko active Application Filing
-
2019
- 2019-01-11 HK HK19100430.7A patent/HK1258053A1/zh unknown
- 2019-03-27 KR KR1020190035405A patent/KR102069730B1/ko active IP Right Grant
-
2020
- 2020-05-20 JP JP2020088146A patent/JP2020143118A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES2866890T3 (es) | 2021-10-20 |
| CN108884066B (zh) | 2021-08-24 |
| AU2017221707A1 (en) | 2018-08-30 |
| HK1258053A1 (zh) | 2019-11-01 |
| EP3418275A1 (en) | 2018-12-26 |
| MX2018009861A (es) | 2019-06-06 |
| CA3014740C (en) | 2021-06-01 |
| US20190047993A1 (en) | 2019-02-14 |
| KR101965326B1 (ko) | 2019-04-03 |
| RU2724957C2 (ru) | 2020-06-29 |
| AU2017221707B2 (en) | 2019-10-03 |
| JP2020143118A (ja) | 2020-09-10 |
| JP2019504900A (ja) | 2019-02-21 |
| CN108884066A (zh) | 2018-11-23 |
| KR102069730B1 (ko) | 2020-01-23 |
| KR20190035671A (ko) | 2019-04-03 |
| CA3014740A1 (en) | 2017-08-24 |
| NZ745210A (en) | 2019-08-30 |
| KR20180136425A (ko) | 2018-12-24 |
| WO2017142325A1 (ko) | 2017-08-24 |
| RU2018130703A3 (da) | 2020-03-17 |
| PT3418275T (pt) | 2021-04-22 |
| EP3418275A4 (en) | 2019-07-17 |
| BR112018016729A2 (pt) | 2018-12-26 |
| EP3418275B1 (en) | 2021-03-17 |
| JP6749422B2 (ja) | 2020-09-02 |
| US10442796B2 (en) | 2019-10-15 |
| BR112018016729B1 (pt) | 2023-10-24 |
| KR20170096599A (ko) | 2017-08-24 |
| RU2018130703A (ru) | 2020-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3418275T3 (da) | Hidtil ukendt 2,3,5-substitueret thiophenforbindelse som proteinkinasehæmmer | |
| DK3442980T3 (da) | Heterocykliske forbindelser som ret-kinase-hæmmere | |
| DK3472167T3 (da) | Heterocykliske forbindelser som immunomodulatorer | |
| DK3436444T3 (da) | Heterocyklisk forbindelse | |
| DK3697785T3 (da) | Imidazo-pyridine forbindelser som pad-inhibitorer | |
| DK3497103T3 (da) | Pyridopyrimdinon-cdk2/4/6-inhibitorer | |
| DK3371190T3 (da) | Heterocykliske forbindelser som pi3k-gamma-inhibitorer | |
| DK3324977T3 (da) | Benzodiazepinderivater som rsv-inhibitorer | |
| DK3377488T3 (da) | Heterocykliske forbindelser som immunomodulatorer | |
| DK3298002T3 (da) | Heterocykliske amider som kinasehæmmere | |
| DK3328849T3 (da) | 1,1,1-trifluor-3-hydroxypropan-2-yl-carbamat-derivater og 1,1,1-trifluor-4-hydroxybutan-2-yl-carbamat-derivater som magl-inhibitorer | |
| DK3728252T3 (da) | 4-azaindolforbindelser | |
| DK3609898T3 (da) | Forbindelser, der er nyttige som ret-hæmmere | |
| DK3582780T3 (da) | Aminopyrimidinforbindelser, der er anvendelige som SSAO-inhibitorer | |
| DK3003038T3 (da) | 2h-1,2,3-triazolderivater som inhibitorer af fibrose | |
| DK3768674T3 (da) | Aminopyrimidinderivater som ctps1-hæmmere | |
| IL267899A (en) | 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives as magl inhibitors | |
| DK3135668T3 (da) | Ny disubstitueret 1,2,4-triazin-forbindelse | |
| DK3762368T3 (da) | Aminopyrazindiolforbindelser som pi3k-y-inhibitorer | |
| DK3544981T3 (da) | Benzodiazoliumforbindelser som enac-inhibitorer | |
| DK3592745T3 (da) | Pyrimidopyrimidinoner anvendelige som Wee-1 kinaseinhibitorer | |
| DK3638680T3 (da) | Heteroaromatiske forbindelser som vanininhibitorer | |
| DK3844161T3 (da) | Heteroaromatiske forbindelser som vanininhibitorer. | |
| DK3552017T3 (da) | Forbindelser, der er anvendelige som ripk1-inhibitorer | |
| MA46615A (fr) | Inhibiteurs de nav1.7 de type acyl-sulfonamide |